News
Videos
Conferences
Events
Resources
Subscribe

|Videos|August 13, 2015

Breast Cancer Treatment

Episodes in this series

EP. 1 Importance of Breast Cancer Screening

EP. 1 Importance of Breast Cancer Screening

EP. 2 Breast Cancer in the Media

EP. 2 Breast Cancer in the Media

EP. 3 Breast Cancer: The 3 Receptors and Treatment

EP. 3 Breast Cancer: The 3 Receptors and Treatment

EP. 4 Breast Cancer Treatment

EP. 4 Breast Cancer Treatment

EP. 5 The Importance of Your Care Team

EP. 5 The Importance of Your Care Team

EP. 6 Communicating With Your Healthcare Team

EP. 6 Communicating With Your Healthcare Team

EP. 7 Breast Cancer: Top Tips for Support

EP. 7 Breast Cancer: Top Tips for Support

EP. 8 Breast Cancer: A Patient's Story

EP. 8 Breast Cancer: A Patient's Story

EP. 9 Breast Cancer: Breaking the News of Cancer

EP. 9 Breast Cancer: Breaking the News of Cancer

EP. 10 Breast Cancer: The Role of the Caregiver

EP. 10 Breast Cancer: The Role of the Caregiver

EP. 11 How Cancer Changes You

EP. 11 How Cancer Changes You

Newsletter

Stay up to date on cancer updates, research and education

Related Content

image of Fda.

FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer

November 13th 2025

Bonnie Annis

When One Blood Draw Could Tell More: A Look at the Cancerguard Test

November 13th 2025

After her own breast cancer treatment, Maureen advocated for legislation to make scalp cooling more accessible for patients seeking to preserve their hair.

Breast Cancer Survivor Advocates for Access to Scalp Cooling

ByMaureen Green

November 12th 2025

For Maureen Green, scalp cooling was a crucial part of her breast cancer treatment journey, as it prevented chemotherapy-induced hair loss.

Scalp Cooling Can Prevent Hair Loss During Chemo for Breast Cancer

November 12th 2025

Image of woman.

Dealing With Peripheral Neuropathy After Breast Cancer Treatment

ByCynthia Malaran

November 12th 2025

Trending on CURE

FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer

FDA Approves Komzifti for NPM1-Mutant Acute Myeloid Leukemia

Cancer Experts Share Emerging Treatments Patients Should Know in 2026

Shared Loss Leads to Lifelong Friendship in Rare Cancer Caregiving

FDA Grants Drug Designation to Tinostamustine for Malignant Glioma

© 2025 MJH Life Sciences^®

All rights reserved.